Table 3: Outcomes for the 175 duodenal ulcer bleeders with different durations of pantoprazole infusion compared to saline infusion.

Outcome (duodenal ulcer bleeders) Saline Pantoprazole all Pantoprazole 0–4 hrs Pantoprazole >4 hrs Pantoprazole >6 hrs
( )( )P value( )P value( )P value( )P value
Number of pts. (%)Number of pts. (%)Number of pts. (%)Number of pts. (%)

Endoscopic signs of bleeding from duodenal ulcers
 Active bleeding14 (29.8%)31 (24.2%)0.4619 (24.6%)0.5312 (23.5%)0.4810 (23.8%)0.53
 Nonbleeding visible vessel7 (14.8%)27 (21.1%)0.3617 (22.0%)0.3310 (19.6%)0.549 (21.4%)0.42
 Clot7 (14.8%)24 (18.7%)0.5516 (20.8%)0.418 (15.7%)0.918 (19.0%)0.60
 Pigmented spot and clean base19 (40.4%)46 (35.9%)0.5925 (32.5%)0.3621 (0.41%)0.9415 (35.7%)0.65
Urgent endoscopy5 (10.6%)11 (8.5%)0.646 (7.8%)0.525 (9.8%)0.823 (7.1%)0.54
Recurrent bleeding9 (19.1%)22 (17.2%)0.7611 (14.2%)0.4711 (21.5%)0.7710 (23.8%)0.59
Emergency surgery 8 (17.0%)15 (12.3%)0.368 (10.4%)0.287 (13.7%)0.816 (14.3%)0.72
Mortality 3 (6.3%)7 (5.7%)0.765 (6.4%)0.982 (3.9%)0.581 (2.3%)0.36

P values were calculated for comparison between saline infusion group and pantoprazole infusion group patients with different durations of pantoprazole administration.